News
-
-
-
-
-
PRESS RELEASE
Zentiva announces voluntary public purchase offer for APONTIS PHARMA – Investment Agreement signed
Zentiva announces voluntary public purchase offer for APONTIS PHARMA with a 52.9% premium over the closing share price on 15 October 2024. Zentiva to acquire approx. 37.5% stake through share sale and purchase agreement with main shareholder